This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • IMMORTAL
      • Kidney Cancer
        • RadiCal
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • ECLIPSE
        • FORT
        • NRG-GU 0101
        • Masofaniten (Oral EPI-7386)
        • RTIRE
        • SHORTER
        • SPLASH
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Suprapubic Catheter
        Diane K. Newman, DNP FAAN BCB-PMD
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • ASTRO 2023
      • SNMMI 2023
      • ProsTIC/PCF Global Webinar 2023
      • ASCO 2023
      • AUA 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Renal Cancer

Recent Abstracts
Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma - Abstract October 3, 2011
Impact of tumor size on renal function and prediction of renal insufficiency after radical nephrectomy in patients with renal cell carcinoma - Abstract October 3, 2011
Retroperitoneoscopic radical nephrectomy with a small incision for renal cell carcinoma: Comparison with the conventional method - Abstract September 30, 2011
Long-term complete response to very-low-dose interleukin-2 therapy in patients with metastatic renal cell carcinoma: Report of two cases - Abstract September 30, 2011
A renal cell carcinoma metastasis to the contralateral perirenal fat : A case report - Abstract September 29, 2011
Incidence and long-term prognosis of papillary renal cancer : Results of a retrospective multicenter study - Abstract September 29, 2011
Sunitinib for Asian patients with advanced renal cell carcinoma: A comparable efficacy with different toxicity profiles - Abstract September 28, 2011
Bladder metastasis of renal cell carcinoma: Report of a case - Abstract September 28, 2011
Cost-effectiveness of sunitinib in metastatic renal cell carcinoma - Abstract September 27, 2011
Therapeutic rationale for mTOR inhibition in advanced renal cell carcinoma - Abstract September 26, 2011
Prognostic model for survival in patients with metastatic renal cell carcinoma: Results from the International Kidney Cancer Working Group - Abstract September 26, 2011
Toxicities of targeted agents in advanced renal cell carcinoma - Abstract September 23, 2011
VEGF inhibitors in metastatic renal cell carcinoma: Current therapies and future perspective - Abstract September 23, 2011
DGU 2011 - Treatment of patients with metastatic renal cell carcinoma: Reality in Germany - Session Highlights September 23, 2011
DGU 2011 - Histologic subtypes of renal cell carcinoma demonstrate different activation of the mTOR pathway - Session Highlights September 23, 2011
Emerging targeted therapies in metastatic renal cell carcinoma - Abstract September 22, 2011
Immunotherapy of kidney cancer - Abstract September 22, 2011
Immunotherapy and targeted therapy combinations in renal cancer - Abstract September 22, 2011
DGU 2011 - Sorafenib (SOR) dosage patterns in > 4600 patients with renal cell carcinoma, including the elderly and patients treated for > 12 months: Results from an integrated database of 8 company-sponsored trials - Session Highlights September 22, 2011
DGU 2011 - Intrinsic resistance to treatment with tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma - Session Highlights September 22, 2011
Page 403 of 420
  • Start
  • Prev
  • 398
  • 399
  • 400
  • 401
  • 402
  • 403
  • 404
  • 405
  • 406
  • 407
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free